Tech Company Financing Transactions
BioCircuit Technologies Funding Round
BioCircuit Technologies, based in Atlanta, secured $9 million from Masters Capital Management, Alsora Capital and GRA Venture Fund.
Transaction Overview
Company Name
Announced On
9/28/2022
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to commercialize its nerve repair device, Nerve Tape®, and develop its therapeutic device designed to improve the gait of patients afflicted with spinal cord injuries, stroke, and a variety of other neurological conditions. First human use is scheduled to occur in 2023.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1819 Peachtree Rd NE 205
Atlanta, GA 30309
USA
Atlanta, GA 30309
USA
Phone
Undisclosed
Website
Email Address
Overview
BioCircuit Technologies is a medical device company developing tools for neural interfacing and tissue repair. As a team of scientists, engineers, and programmers, BioCircuit is dedicated to the translation of cutting-edge neurotechnology research into powerful, yet practical, clinical tools.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michelle Jarrard
Chief Technical Officer
Isaac Clements
Browse more venture capital transactions:
Prev: 9/28/2022: Sudo Biosciences venture capital transaction
Next: 9/28/2022: Qnovia venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs